Literature DB >> 31905240

Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy.

Joan Cox Gill1,2,3, Stephen F Conley4, Victoria P Johnson3, Pamela A Christopherson3, Sandra L Haberichter1,2,3, Christina D Diaz5, Tatyana C Strong5, Jian Zhang6, Pippa Simpson6, Thomas C Abshire1,2,3, Robert R Montgomery1,2,3, Veronica H Flood1,2,3.   

Abstract

von Willebrand disease is a common bleeding disorder, but diagnosis can be difficult in young children who have not had bleeding challenges. We sought to evaluate the correlation between bleeding and von Willebrand factor (VWF) levels in children undergoing surgical challenge with tonsillectomy. Children ages 0 to 18 undergoing tonsillectomy without a personal or family history of bleeding were enrolled prospectively following informed consent and institutional review board approval. VWF levels were obtained at the time of surgery. VWF antigen (VWF:Ag) and VWF activity (VWF:GPIbM) were tested via enzyme-linked immunosorbent assay. Bleeding score was calculated using the International Society of Hematology bleeding assessment tool (BAT). Surgical and postoperative bleeding were determined using questionnaires filled out by the surgeon and patient/family. A total of 1399 subjects were enrolled with evaluable data, with a median age of 5 years. The median VWF:Ag was 85 IU/dL and the median VWF:GPIbM was 100 U/dL. Median BAT for the entire population was 0, including those with postoperative bleeding. There was no difference in VWF level between those who experienced postoperative bleeding and those who did not, with median VWF:Ag 85 vs 85 (P = .89) and mean VWF:GPIbM 98 vs 100 (P = .5). Interestingly, there was a difference in VWF levels with age, with median VWF:Ag 81 for those younger than 3 years, 82 for those 3 to 6 years, 90 for those 7 to 10 years, and 100 for those 11 to 18 years. A similar trend was noted for VWF:GPIbM. Of the 2 to 6 year olds, 5% had VWF:Ag <50, which would meet criteria for low VWF, but only 1.8% had an abnormal BAT at study entry and only 2.5% bled after surgery. Only 1 subject with low VWF had an elevated postoperative BAT >2. These data suggest that low VWF levels do not correlate with bleeding in children undergoing tonsillectomy. In addition, VWF levels outside the adult normal range in young children may be more common than previously thought and do not necessarily predict surgical bleeding.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31905240      PMCID: PMC6960478          DOI: 10.1182/bloodadvances.2019000992

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  23 in total

1.  Screening for undiagnosed bleeding disorders in post-tonsillectomy bleed patients: Retrospective review and systematic review of the literature.

Authors:  Sarah A Gitomer; Grace Shebha Anand; Hallie E Bradley; Manish Kumar; Lara Ouellette; Mary F Musso
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-06-10       Impact factor: 1.675

2.  Reducing the use of inappropriate coagulation testing in emergency general surgical patients.

Authors:  Lydiya Thomas; EeLaine Woon; Elizabeth Fong; Craig Parnaby; Henry G Watson
Journal:  Scott Med J       Date:  2018-06-26       Impact factor: 0.729

3.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Authors:  F Rodeghiero; A Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 4.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

5.  Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

Authors:  Veronica H Flood; Joan Cox Gill; Patricia A Morateck; Pamela A Christopherson; Kenneth D Friedman; Sandra L Haberichter; Brian R Branchford; Raymond G Hoffmann; Thomas C Abshire; Jorge A Di Paola; W Keith Hoots; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
Journal:  Blood       Date:  2010-03-15       Impact factor: 22.113

6.  Recurrent post tonsillectomy bleeds: Presentation and characteristics in the paediatric population.

Authors:  Graeme van der Meer; Maayan Gruber; Murali Mahadevan
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2017-05-02       Impact factor: 1.675

7.  Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

Authors:  Veronica H Flood; Joan Cox Gill; Patricia A Morateck; Pamela A Christopherson; Kenneth D Friedman; Sandra L Haberichter; Raymond G Hoffmann; Robert R Montgomery
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

8.  Preoperative screening for coagulation disorders in children undergoing adenoidectomy (AT) and tonsillectomy (TE): does it prevent bleeding complications?

Authors:  S Eisert; M Hovermann; H Bier; U Göbel
Journal:  Klin Padiatr       Date:  2006 Nov-Dec       Impact factor: 1.349

Review 9.  Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology.

Authors:  Y L Chee; J C Crawford; H G Watson; M Greaves
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

10.  Our experience with pre-operative haemostatic assessment of paediatric patients undergoing adenotonsillectomy at Federal Medical Centre, Makurdi.

Authors:  Amali Adekwu; Agida Samuel Adoga; Terna Ambrose Gav
Journal:  Afr J Paediatr Surg       Date:  2016 Apr-Jun
View more
  6 in total

Review 1.  Von Willebrand Disease: Current Status of Diagnosis and Management.

Authors:  Angela C Weyand; Veronica H Flood
Journal:  Hematol Oncol Clin North Am       Date:  2021-08-13       Impact factor: 3.722

Review 2.  Low VWF: insights into pathogenesis, diagnosis, and clinical management.

Authors:  James S O'Donnell
Journal:  Blood Adv       Date:  2020-07-14

3.  The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

Authors:  Lakshmi Srivaths; Charles G Minard; Sarah H O'Brien; Allison P Wheeler; Eric Mullins; Mukta Sharma; Robert Sidonio; Shilpa Jain; Ayesha Zia; Margaret V Ragni; Roshni Kulkarni; Jennifer E Dietrich; Peter A Kouides
Journal:  Blood Adv       Date:  2020-07-14

4.  Screening for von Willebrand disease does not impact posttonsillectomy bleeding in a low-risk population.

Authors:  Stefanie Digiandomenico; Stephen F Conley; Victoria P Johnson; Pamela A Christopherson; Sandra L Haberichter; Jian Zhang; Pippa Simpson; Thomas C Abshire; Robert R Montgomery; Veronica H Flood
Journal:  Pediatr Blood Cancer       Date:  2021-10-04       Impact factor: 3.167

5.  Reevaluation of von Willebrand disease diagnosis in a Croatian paediatric cohort combining bleeding scores, phenotypic laboratory assays and next generation sequencing: a pilot study.

Authors:  Ivana Lapić; Margareta Radić Antolic; Sara Dejanović Bekić; Désirée Coen-Herak; Ernest Bilić; Dunja Rogić; Renata Zadro
Journal:  Biochem Med (Zagreb)       Date:  2022-02-15       Impact factor: 2.313

6.  Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Martin Bergstrand; Emma Hansson; Bernard Delaey; Filip Callewaert; Rui De Passos Sousa; Maria Laura Sargentini-Maier
Journal:  J Clin Pharmacol       Date:  2021-11-29       Impact factor: 2.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.